Net Worth

Net Worth: $2.4 billion Billionaire
$2.4 billion
$1B $3.25B $5.5B $7.75B $10B

Wealth Tier: Billionaire

Net worth between $1 billion and $10 billion

Annual Income

$50 million annually from business dividends

Net Worth Timeline

2022: $1,900,000,000, 2023: $2,000,000,000, 2024: $2,400,000,000

Viktor Kharitonin's Biography

Viktor Kharitonin is a prominent Russian businessman and billionaire best known for co-founding Pharmstandard, one of Russia’s largest pharmaceutical companies. Born on May 10, 1972, Kharitonin graduated from Moscow State University and quickly became a key player in the Russian pharma industry. His major breakthrough came in 2003 with the foundation of Pharmstandard, which soon launched Arbidol, a popular painkiller and antiviral drug in Russia. Under his leadership, Pharmstandard grew rapidly, making Kharitonin one of the wealthiest individuals in the country. Beyond pharmaceuticals, Viktor Kharitonin has diversified his interests into motorsports, notably acquiring a significant stake in the historic Nürburgring racetrack in Germany. Despite his wealth, Kharitonin maintains a low public profile, rarely appearing in the media and keeping his personal life private. As of 2024, his estimated net worth stands at $2.4 billion, according to Forbes. Known for his keen business sense and investments in both healthcare and automotive sectors, Kharitonin is recognized as a visionary in Russian industry. His interests span innovation in medicine, motorsports, and classic car collection, reflecting his dynamic approach to both business and lifestyle.

Wealth in Perspective

Fun Fact

He is a co-owner of Germany’s iconic Nürburgring racing circuit.

Full Name

Viktor Kharitonin

Nickname

Viktor

Nationality

Russian

Birthday

May 10, 1972

Age

53

Zodiac Sign

Taurus

Height

180 cm cm

Weight

85 kg kg

Marital Status

Married

Spouse

Unknown

Children

2

Education

Moscow State University

Famous For

Co-founding Pharmstandard, one of Russia’s largest pharmaceutical companies

First Big Break

Co-founding Pharmstandard in 2003 and launching the successful painkiller Arbidol

Social Media

Not publicly available

Businesses Owned

Pharmstandard, Nizhpharm, shares in Nürburgring racetrack

Awards

Included in Forbes Russian Billionaires list

Category

Business

Controversies

Faced scrutiny due to business activities during Russian pharmaceutical market reforms

Hobbies

Motorsports, classic car collection

Interests

Pharmaceutical innovation, business investments, racing

Quote

Success in business is about vision and persistence.

Share this profile